Clinical Trial Update: A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™ [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study in healthy Asian and Caucasian volunteers to characterize the PK profile of Eurartesim; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Eurartesim (piperaquine tetraphosphate; artenimol)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Malaria, Falciparum | Phase 1 | Status: COMPLETED